Keros Therapeutics
KROS
#6165
Rank
$0.68 B
Marketcap
$17.03
Share price
0.65%
Change (1 day)
-55.43%
Change (1 year)

P/S ratio for Keros Therapeutics (KROS)

P/S ratio as of December 2024 (TTM): > 1000

According to Keros Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.29. At the end of 2024 the company had a P/S ratio of > 1000.

P/S ratio history for Keros Therapeutics from 2020 to 2024

PS ratio at the end of each year

Year P/S ratio Change
2024> 1000-58.76%
2023> 1000
2022N/A-100%
202168.1
2020N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA